Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merz Pharmaceuticals GmbH
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged between 18 and 75 years with a clinical diagnosis of first onset, persistent (i.e., tinnitus should never be absent for \> 24 hours in a row), subjective, uni- or bilateral subacute tinnitus
You may not be if
Clinical diagnosis of intermittent or pulsatile tinnitus
Patients who have tinnitus as a concomitant symptom of an otological/neurological disease (such as otitis media, Menière's disease, otosclerosis, etc)
Clareo Health | Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
